Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

147.50p
   
  • Change Today:
    -2.50p
  • 52 Week High: 248.00
  • 52 Week Low: 145.00
  • Currency: UK Pounds
  • Shares Issued: 44.96m
  • Volume: 5,000
  • Market Cap: 66.32m
  • Beta: 0.23

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-18 Interim 25.34 (2.85) (6.60)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 21.16 0.78 2.40p 63.5 n/a n/a n/a 0.0%
31-Dec-15 30.18 2.07 9.50p 17.8 0.1 +296% n/a 0.0%
31-Dec-16 39.23 (0.22) 6.80p 22.4 n/a -28% n/a 0.0%
31-Dec-17 47.62 (4.45) 4.20p 43.7 n/a -38% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 51.29 (0.20) (0.55)p n/a n/a n/a n/a 0.0%
31-Dec-19 58.19 5.28 9.63p 15.6 n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 43.69 17.84 n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Ergomed Market Data

Currency UK Pounds
Share Price 147.50p
Change Today -2.50p
% Change -1.67 %
52 Week High 248.00
52 Week Low 145.00
Volume 5,000
Shares Issued 44.96m
Market Cap 66.32m
Beta 0.23

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.97% below the market average16.97% below the market average16.97% below the market average16.97% below the market average16.97% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend Not Available
Income Not Available
Growth
33.49% above the market average33.49% above the market average33.49% above the market average33.49% above the market average33.49% above the market average
10.53% above the sector average10.53% above the sector average10.53% above the sector average10.53% above the sector average10.53% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 15-Nov-2018

Time Volume / Share Price
15:40 5,000 @ 145.00p
13:47 5,000 @ 147.50p
10:27 11,800 @ 145.00p

Ergomed Key Personnel

Chair Peter George
CEO Stephen Stamp
COO Jan Petracek
CFO Stuart Jackson

Top of Page